Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver spray versus Betadine for wound healing and surgical site infection in open lower limb fractures
IRCT20251113067986N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of povidone-iodine in open lower limb fracture and Surgical wound (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Surgical site infection rate. Started Dec 2025; status: completed.
02
Drugs
povidone-iodine
03
Conditions
open lower limb fractureSurgical wound
Beyond the preview
Go deeper on IRCT20251113067986N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251113067986N1.